Roche Nears Deal to Buy Spark Therapeutics for Close to 5 Billion

Get the Full StoryRoche Holding AG is nearing a deal to buy Philadelphia biotech company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.

Share: